Efficacy and Safety of Dengue Vaccine in Healthy Children Aged 4 to 11 Years in Thailand.

Trial Profile

Efficacy and Safety of Dengue Vaccine in Healthy Children Aged 4 to 11 Years in Thailand.

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Jun 2018

At a glance

  • Drugs CYD TDV (Primary) ; Rabies vaccine
  • Indications Dengue
  • Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
  • Sponsors sanofi pasteur
  • Most Recent Events

    • 13 Jun 2018 Results of post-hoc analysis assessing effect of dengue serostatus on vaccine safety and efficacy by using data from four trials including this trial published in the New England Journal of Medicine.
    • 18 Apr 2016 Results published in the Vaccine
    • 13 Oct 2015 Results of this and other two trials (see profile 200702 and 200833) published in the Vaccine
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top